Pharmaceutical Packaging and Labeling for Hazardous Medical Products

The contract requires the provision of compliant packaging, labeling, and documentation for Rho(D) Immune Globulin in strict accordance with military and federal regulations, including MIL-STD-129, 49 CFR, ICAO, and Medical Marking Standard No. 1. This subcontract is part of a Department of Defense initiative under the Medical Supply Chain Pharm FSA, with all work to be performed at FPO, 96666, ensuring that hazardous medical products meet the stringent safety and identifiability standards required for defense logistics. The packaging and labeling must support safe transportation, handling, and administration of the product within federal and international transit systems. The solicitation, posted on August 9, 2026, with a response deadline of August 17, 2026, falls under NAICS code 325811 for pharmaceutical preparation manufacturing. The nature of the contract demands full alignment with hazardous materials regulations and medical marking guidelines, emphasizing traceability, durability, and clarity of information under operational conditions. All submissions must demonstrate proven capability to deliver compliant solutions that satisfy Department of Defense requirements without exception, ensuring the product’s integrity from manufacturer through to point of use in military medical environments.